Eugia SEZ’s injectable facility gets EIR from USFDA
The Unit has now received Establishment Inspection Report classifying the facility as Voluntary Action Indicated
The Unit has now received Establishment Inspection Report classifying the facility as Voluntary Action Indicated
Glenmark released Picture Post Cards on World Vitiligo Day
Combined entity is better positioned to compete in increasingly competitive generics industry
Fischer MVL envisages to offer a diverse portfolio of diagnostic solutions
his strategic collaboration with BluSim Tech marks a significant milestone in Fischer MVL's journey towards expanding its healthcare portfolio
Canagliflozin and Metformin Hydrochloride Tablets are used to treat type 2 diabetes mellitus
Merck shared updates on the company’s oncology pipeline and focused R&D approach
The Profit After Tax (PAT) for Q4 FY24 at Rs 36.40 crore, compared to Rs 38.23 crore in Q4 FY23
Strategic focus on India aims to make the Swoop® portable MR brain imaging system commercially available in a vast and underserved MRI market
Subscribe To Our Newsletter & Stay Updated